346 related articles for article (PubMed ID: 30638965)
1. [Gaucher disease: A review].
Nguyen Y; Stirnemann J; Belmatoug N
Rev Med Interne; 2019 May; 40(5):313-322. PubMed ID: 30638965
[TBL] [Abstract][Full Text] [Related]
2. A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Stirnemann J; Belmatoug N; Camou F; Serratrice C; Froissart R; Caillaud C; Levade T; Astudillo L; Serratrice J; Brassier A; Rose C; Billette de Villemeur T; Berger MG
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218669
[TBL] [Abstract][Full Text] [Related]
3. [Gaucher disease].
Nguyen Y; Stirnemann J; Belmatoug N
Rev Prat; 2020 Apr; 70(4):416-420. PubMed ID: 32877100
[TBL] [Abstract][Full Text] [Related]
4. Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
Dandana A; Ben Khelifa S; Chahed H; Miled A; Ferchichi S
Pathobiology; 2016; 83(1):13-23. PubMed ID: 26588331
[TBL] [Abstract][Full Text] [Related]
5. [Gaucher Disease].
Okuyama T
Brain Nerve; 2015 Sep; 67(9):1109-13. PubMed ID: 26329151
[TBL] [Abstract][Full Text] [Related]
6. Enzyme Replacement Therapy in a Gaucher Family.
Erdem N; Buran T; Berber I; Aydogdu I
J Natl Med Assoc; 2018 Aug; 110(4):330-333. PubMed ID: 30126557
[TBL] [Abstract][Full Text] [Related]
7. [Misdiagnosis of Gaucher disease in real life: Retrospective study of the French Gaucher's disease registry].
Perez Y; Belmatoug N; Bengherbia M; Yousfi K; Lioger B
Rev Med Interne; 2023 Feb; 44(2):55-61. PubMed ID: 36669934
[TBL] [Abstract][Full Text] [Related]
8. Hematological manifestations and complications of Gaucher disease.
Linari S; Castaman G
Expert Rev Hematol; 2016 Jan; 9(1):51-8. PubMed ID: 26565753
[TBL] [Abstract][Full Text] [Related]
9. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
[TBL] [Abstract][Full Text] [Related]
10. Advancements in Viral Gene Therapy for Gaucher Disease.
Kulkarni A; Chen T; Sidransky E; Han TU
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540423
[TBL] [Abstract][Full Text] [Related]
11. The clinical management of Type 2 Gaucher disease.
Weiss K; Gonzalez A; Lopez G; Pedoeim L; Groden C; Sidransky E
Mol Genet Metab; 2015 Feb; 114(2):110-122. PubMed ID: 25435509
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmological findings in Gaucher disease.
Eghbali A; Hassan S; Seehra G; FitzGibbon E; Sidransky E
Mol Genet Metab; 2019 May; 127(1):23-27. PubMed ID: 31047801
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
Ceravolo F; Grisolia M; Sestito S; Falvo F; Moricca MT; Concolino D
J Med Case Rep; 2017 Jan; 11(1):19. PubMed ID: 28103924
[TBL] [Abstract][Full Text] [Related]
14. Gaucher Disease for Hematologists.
Özdemir GN; Gündüz E
Turk J Haematol; 2022 Jun; 39(2):136-139. PubMed ID: 35439918
[TBL] [Abstract][Full Text] [Related]
15. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
[TBL] [Abstract][Full Text] [Related]
16. The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.
Sawicka-Gutaj N; Machaczka M; Kulińska-Niedziela I; Bernardczyk-Meller J; Gutaj P; Sowiński J; Ruchała M
Ups J Med Sci; 2016 Aug; 121(3):192-5. PubMed ID: 27064303
[TBL] [Abstract][Full Text] [Related]
17. Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy.
Tezuka Y; Fukuda M; Watanabe S; Nakano T; Okamoto K; Kuzume K; Yano Y; Eguchi M; Ishimae M; Ishii E; Miyazaki T
Blood Cells Mol Dis; 2018 Feb; 68():194-199. PubMed ID: 27866810
[TBL] [Abstract][Full Text] [Related]
18. Management of bone disease in Gaucher disease type 1: clinical practice.
Giuffrida G; Cappellini MD; Carubbi F; Di Rocco M; Iolascon G
Adv Ther; 2014 Dec; 31(12):1197-212. PubMed ID: 25515322
[TBL] [Abstract][Full Text] [Related]
19. Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis.
Cappellini MD; Motta I; Barbato A; Giuffrida G; Manna R; Carubbi F; Giona F
Eur J Intern Med; 2023 Feb; 108():81-84. PubMed ID: 36443133
[TBL] [Abstract][Full Text] [Related]
20. Exploring genetic modifiers of Gaucher disease: The next horizon.
Davidson BA; Hassan S; Garcia EJ; Tayebi N; Sidransky E
Hum Mutat; 2018 Dec; 39(12):1739-1751. PubMed ID: 30098107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
